Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$378K Buy
+3,200
New +$369K ﹤0.01% 4970
2025
Q1
Sell
-13,500
Closed -$1.57M 6483
2024
Q4
$1.57M Buy
13,500
+10,900
+419% +$1.38M ﹤0.01% 3832
2024
Q3
$351K Sell
2,600
-9,100
-78% -$1.22M ﹤0.01% 5101
2024
Q2
$1.59M Buy
11,700
+9,100
+350% +$1.24M ﹤0.01% 3735
2024
Q1
$336K Buy
+2,600
New +$314K ﹤0.01% 5058
2023
Q1
Sell
-1,900
Closed -$210K 6940
2022
Q4
$210K Buy
+1,900
New +$199K ﹤0.01% 5308

Other funds holding XYL

Israel Englander's XYL Position: Q2 2026 in Review

Israel Englander reduced its Xylem (XYL) stake by 4.6% in Q2 2026, selling an estimated $1.83M and leaving 331,004 shares worth $39.1M. The position accounts for 0.01% of the portfolio, ranked #1054.

Israel Englander first reported a position in XYL in Q2 2013 and has held it in 50 quarters since. The position peaked at $216M in Q2 2023. 1,090 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Israel Englander held 331,004 shares of Xylem worth $39.1M as of Q2 2026.
  • Israel Englander sold 15,861 Xylem shares in Q2 2026, an estimated $1.83M.
  • Xylem made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1054 holding.
  • Israel Englander first reported a position in Xylem in Q2 2013 and has held it in 50 quarters since.
  • Israel Englander's Xylem position peaked at $216M in Q2 2023.
  • 1,090 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.